Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sigurd D Süssmuth

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Clinical and Translational Science|December 23, 2024
Safety of BI 1358894 in patients with major depressive disorder: Results and learnings from a phase II randomized decentralized clinical trialChristopher Reist, Peide Li, Thuy Le Nguyen, et al.
Neuroscience Letters|December 4, 2003
Amyotrophic lateral sclerosis: disease stage related changes of tau protein and S100 beta in cerebrospinal fluid and creatine kinase in serumSigurd D Süssmuth, Hayrettin Tumani, Daniel Ecker, et al.
Current Medicinal Chemistry|August 12, 2008
Biochemical markers in CSF of ALS patientsSigurd D Süssmuth, Johannes Brettschneider, Albert C Ludolph, et al.
Neurochemical Research|March 25, 2010
Hypercapnia is a possible determinant of the function of the blood-cerebrospinal fluid barrier in amyotrophic lateral sclerosisSigurd D Süssmuth, Anne D Sperfeld, Albert C Ludolph, et al.
Journal of the Neurological Sciences|January 29, 2010
CIS case studiesHayrettin Tumani, Irina Sapunova-Mayer, Sigurd D Süssmuth, et al.
Translational Psychiatry|August 11, 2022
Quantitative electroencephalography parameters as neurophysiological biomarkers of schizophrenia-related deficits: A Phase II substudy of patients treated with iclepertin (BI 425809)Christian Schultheis, Holger Rosenbrock, Salome Rebecca Mack, et al.
Cells|September 30, 2020
Tick-Borne Encephalitis: A Differential Pattern of Intrathecal Humoral Immune Response and Inflammatory Cell Composition Compared with Other Viral CNS InfectionsMakbule Senel, Daniel Rapp, Benjamin Mayer, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 3, 2006
Neurofilament heavy-chain NfH(SMI35) in cerebrospinal fluid supports the differential diagnosis of Parkinsonian syndromesJohannes Brettschneider, Axel Petzold, Sigurd D Süssmuth, et al.
Plos Currents|March 30, 2012
Stability effects on results of diffusion tensor imaging analysis by reduction of the number of gradient directions due to motion artifacts: an application to presymptomatic Huntington's diseaseHans-Peter Müller, Sigurd D Süssmuth, G Bernhard Landwehrmeyer, et al.
Muscle & Nerve|July 30, 2013
Novel ETFDH mutation and imaging findings in an adult with glutaric aciduria type IIAngela Rosenbohm, Sigurd D Süssmuth, Jan Kassubek, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Clinical and Translational Science|December 23, 2024
Safety of BI 1358894 in patients with major depressive disorder: Results and learnings from a phase II randomized decentralized clinical trialChristopher Reist, Peide Li, Thuy Le Nguyen, et al.
Neuroscience Letters|December 4, 2003
Amyotrophic lateral sclerosis: disease stage related changes of tau protein and S100 beta in cerebrospinal fluid and creatine kinase in serumSigurd D Süssmuth, Hayrettin Tumani, Daniel Ecker, et al.
Current Medicinal Chemistry|August 12, 2008
Biochemical markers in CSF of ALS patientsSigurd D Süssmuth, Johannes Brettschneider, Albert C Ludolph, et al.
Neurochemical Research|March 25, 2010
Hypercapnia is a possible determinant of the function of the blood-cerebrospinal fluid barrier in amyotrophic lateral sclerosisSigurd D Süssmuth, Anne D Sperfeld, Albert C Ludolph, et al.
Journal of the Neurological Sciences|January 29, 2010
CIS case studiesHayrettin Tumani, Irina Sapunova-Mayer, Sigurd D Süssmuth, et al.
Translational Psychiatry|August 11, 2022
Quantitative electroencephalography parameters as neurophysiological biomarkers of schizophrenia-related deficits: A Phase II substudy of patients treated with iclepertin (BI 425809)Christian Schultheis, Holger Rosenbrock, Salome Rebecca Mack, et al.
Cells|September 30, 2020
Tick-Borne Encephalitis: A Differential Pattern of Intrathecal Humoral Immune Response and Inflammatory Cell Composition Compared with Other Viral CNS InfectionsMakbule Senel, Daniel Rapp, Benjamin Mayer, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 3, 2006
Neurofilament heavy-chain NfH(SMI35) in cerebrospinal fluid supports the differential diagnosis of Parkinsonian syndromesJohannes Brettschneider, Axel Petzold, Sigurd D Süssmuth, et al.
Plos Currents|March 30, 2012
Stability effects on results of diffusion tensor imaging analysis by reduction of the number of gradient directions due to motion artifacts: an application to presymptomatic Huntington's diseaseHans-Peter Müller, Sigurd D Süssmuth, G Bernhard Landwehrmeyer, et al.
Muscle & Nerve|July 30, 2013
Novel ETFDH mutation and imaging findings in an adult with glutaric aciduria type IIAngela Rosenbohm, Sigurd D Süssmuth, Jan Kassubek, et al.
Pageof 3